View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB50 Publication ID: Fall 2020 
Title: Amendments to the Drug Enforcement Administration Hearing Regulations 
Abstract:

This rule proposes to amend the Drug Enforcement Administration hearing regulations that govern the procedures in administrative hearings to deny, revoke, or suspend a DEA registration to handle controlled substances or listed chemicals.

 
Agency: Department of Justice(DOJ)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
EO 13771 Designation: Not subject to, not significant 
CFR Citation: 21 CFR 1300 and 1301    21 CFR 1303    21 CFR 1308 and 1309    21 CFR 1312 and 1313    21 CFR 1315 and 1316    21 CFR 1321   
Legal Authority: 21 U.S.C. 875 to 877   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  05/00/2021 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Scott A. Brinks
Section Chief, Regulatory Drafting and Support Section, Diversion Control Division
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:571 362-8209
Email: scott.a.brinks@dea.gov